LeMaitre Vascular, Inc.

LMAT · Medical Instruments · $1.8B
Turning up
LMAT
$78.87
▼ −0.76%
09/18 O 79.25 H 79.60 L 78.51 C 78.87 ▼ −0.76%
Vol 399.4K RS 10
RS rating10
Now vs pivot (%)−31.61%
Tightening (ATR ratio)1.43×
Volume dry-up1.32×
Up/down volume, net-0.20
From 52-week high33%
played out
Previous breakout trailed out ▼ −5.65% in Feb
Turning up
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

The read

The base has run 6.4 weeks and fell 12% from its ceiling at its deepest. The pivot is $115.33, and the stock closed 31.6% below it. Its relative strength rating is 10.

Also on
Peers
Same theme
No themes — common and fine.
Catalyst roadmap
  1. Earningstentativein 48d
    Quarterly earnings
    Nov 5, 2026
Flagged by the market sweep

Nothing flagged for this company on the last market sweep.

In the news
PAHC or LMAT: Which Is the Better Value Stock Right Now?Zacks Investment Research · 2026-09-02

Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.

Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
LeMaitre Vascular, Inc. (LMAT) — The Tape